4.1 Article

Clinical Features for Severely and Critically III Patients with COVID-19 in Shandong: A Retrospective Cohort Study

Journal

THERAPEUTICS AND CLINICAL RISK MANAGEMENT
Volume 17, Issue -, Pages 9-21

Publisher

DOVE MEDICAL PRESS LTD
DOI: 10.2147/TCRM.S280079

Keywords

SARS-CoV-2; COVID-19; clinical features; severely ill patients; critically ill patients

Funding

  1. National Natural Science Foundation of China [81070016, 81270072, 81770029]
  2. National Key Research and Development Project [2017YFC1310601]
  3. Key Research Project of Shandong Province [2017GSF218056, 2020SFXGFY03-1, 2020SFXGFY03-3, 2020SFXGFY04]

Ask authors/readers for more resources

This study found significant differences in white blood cell counts, procalcitonin levels, D-dimer levels, hemoglobin levels, and lymphocyte counts between severely ill and critically ill patients with SARS-CoV-2 pneumonia. A lymphocyte count less than 10(9)/L upon admission may be the most critical independent factor associated with progression to critical illness.
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel pathogen, has caused an outbreak of coronavirus disease 2019 (COVID-19) that has spread rapidly around the world. Determining the risk factors for death and the differences in clinical features between severely ill and critically ill patients with SARS-CoV-2 pneumonia has become increasingly important. Aim: This study was intended to provide insight into the difference between severely ill and critically ill patients with SARS-CoV-2 pneumonia. Methods: In this retrospective, multicenter cohort study, we enrolled 62 seriously ill patients with SARS-CoV-2 pneumonia who had been diagnosed by March 12, 2020. Clinical data, laboratory indexes, chest images, and treatment strategies collected from routine medical records were compared between severely ill and critically ill patients. Univariate and multivariate logistic regression analyses were also conducted to identify the risk factors associated with the progression of patients with severe COVID-19. Results: Of the 62 patients with severe or critical illness, including 7 who died, 30 (48%) patients had underlying diseases, of which the most common was cardiovascular disease (hypertension, 34%, and coronary heart disease, 5%). Compared to patients with severe disease, those with critical disease had distinctly higher white blood cell counts, procalcitonin levels, and D-dimer levels, and lower hemoglobin levels and lymphocyte counts. Multivariate regression showed that a lymphocyte count less than 10(9)/L (odds ratio 20.92, 95% CI 1.76-248.18; p=0.02) at admission increased the risk of developing a critical illness. Conclusion: Based on multivariate regression analysis, a lower lymphocyte count (<10(9)/L) on admission is the most critical independent factor that is closely associated with an increased risk of progression to critical illness. Age, underlying diseases, especially hypertension and coronary heart disease, elevated D-dimer, decreased hemoglobin, and SOFA score, and APACH score also need to be taken into account for predicting disease progression. Blood cell counts and procalcitonin levels for the later secondary bacterial infection have a certain reference values.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available